Next Article in Journal
Dactylospongia elegans—A Promising Drug Source: Metabolites, Bioactivities, Biosynthesis, Synthesis, and Structural-Activity Relationship
Next Article in Special Issue
Monocaprin Enhances Bioavailability of Fucoxanthin in Diabetic/Obese KK-Ay Mice
Previous Article in Journal
Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications
Previous Article in Special Issue
Fucoxanthin Pretreatment Ameliorates Visible Light-Induced Phagocytosis Disruption of RPE Cells under a Lipid-Rich Environment via the Nrf2 Pathway
 
 
Article

Article Versions Notes

Mar. Drugs 2022, 20(4), 220; https://doi.org/10.3390/md20040220
Action Date Notes Link
article xml file uploaded 22 March 2022 10:44 CET Original file -
article xml uploaded. 22 March 2022 10:44 CET Update https://www.mdpi.com/1660-3397/20/4/220/xml
article pdf uploaded. 22 March 2022 10:44 CET Version of Record https://www.mdpi.com/1660-3397/20/4/220/pdf
article html file updated 22 March 2022 10:45 CET Original file -
article html file updated 1 August 2022 06:56 CEST Update https://www.mdpi.com/1660-3397/20/4/220/html
Back to TopTop